2025 AACR Cancer and Biomedical Research Career Fair
Find your next job—or your next hire—at the AACR Cancer and Biomedical Research Career Fair Saturday, April 26 at the AACR Annual Meeting.
Related Articles
Daily Takeaways From the AACR Annual Meeting 2025: Sunday, April 27
Takeaways from day three of the AACR Annual Meeting 2025 included the Opening Ceremony, a panel on cancer research at a crossroads, and more.
Off-the-shelf CAR Natural Killer Cell Therapy with Logic Gates Elicits Complete Remissions in Relapsed or Refractory Blood Cancers
Several patients with AML, who were treated with SENTI-202 experienced a complete remission after not responding to or having relapsed following prior treatments, according to…
Pretrained Machine Learning Models May Help Accurately Diagnose Nonmelanoma Skin Cancer in Resource-limited Settings
AI models, pretrained on vast datasets, significantly outperformed a standard baseline model in identifying nonmelanoma skin cancers from digital images of tissue samples, according to…
AI-driven Biomarker Model May Improve Detection of Cancer Cachexia
A multimodal, AI-driven model that analyzes routinely collected imaging and clinical information led to more accurate prediction of cancer cachexia than standard methods, according to…
Third Plenary Session to focus on the role of technological advances – AACR Annual Meeting News
Monday’s plenary platform will present four technologies helping to chart new horizons in oncology by advancing our understanding of cancer and developing better therapies for…
Adjuvant PD-1 Blockade for Mismatch Repair-deficient Solid Cancers Directed by ctDNA Status Delivers Clinical Benefit
Pembrolizumab cleared minimal residual disease and protected against recurrence in patients with DNA mismatch repair-deficient early-stage solid cancers who had detectable circulating tumor DNA after…
Exhibitor Floor Plan – AACR Annual Meeting 2025
Search for booth space by size, type or location with the exhibitor floor plan.
AACR Presidential Address and Presidential Select Symposium will take a global view on cancer – AACR Annual Meeting News
AACR President Patricia M. LoRusso, DO, PhD (hc), FAACR, will address efforts to accelerate research and advance personalized medicine around the world.
Neoadjuvant PD-1 Blockade in Early-stage Mismatch Repair-deficient Cancers Can Eliminate the Need for Surgery Regardless of Tumor Type
PD-1 immunotherapy can eliminate the need for surgery in patients with early-stage, DNA mismatch repair-deficient solid cancers, according to results presented at the AACR Annual…
Adding Perioperative Pembrolizumab to Standard of Care Improves Outcomes in Patients With Newly Diagnosed Head and Neck Cancer
Supplementing standard therapy with perioperative PD-1 blockade benefitted patients with untreated, locally advanced head and neck cancer in a phase III clinical trial, according to…